Prognostic value of promoter hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in prostate cancer
作者： A. Ameri , A. Alidoosti , Y. Hosseini , M. Parvin , M. H. Emranpour
DOI: 10.1007/S11670-011-0306-X
关键词:
摘要: Objective The molecular mechanism of prostate cancer is poorly understood. The aim the study was to investigate prevalence and prognostic value promoter hypermethylation retinoic acid receptor beta (RARB) p16 among benign prostatic hyperplasia (BPH) patients.
springer.com
amegroups.com参考文章(39)
Sabine Zöchbauer-Müller, Arthur Sagalowsky, John D. Minna, Bogdan Czerniak, Funda Vakar-Lopez, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Alfredo J. Farinas, Kiyomi O. Toyooka, Kenichi Harada, Riichiroh Maruyama, Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features Cancer Research. ,vol. 61, pp. 8659- 8663 ,(2001)
Carol Salem, Gangning Liang, Yvonne C Tsai, Jane Coulter, Margaret A Knowles, An-Chen Feng, Susan Groshen, Peter W Nichols, Peter A Jones, None, Progressive Increases in de Novo Methylation of CpG Islands in Bladder Cancer Cancer Research. ,vol. 60, pp. 2473- 2476 ,(2000)
Sabine Zöchbauer-Müller, John D. Minna, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Eugene P. Frenkel, Alfredo J. Farinas, John McConnell, Kiyomi O. Toyooka, Riichiroh Maruyama, Aberrant Promoter Methylation Profile of Prostate Cancers and Its Relationship to Clinicopathological Features Clinical Cancer Research. ,vol. 8, pp. 514- 519 ,(2002)
Karen Woodson, Richard Hayes, Louise Wideroff, Liza Villaruz, Joseph Tangrea, Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. The Prostate. ,vol. 55, pp. 199- 205 ,(2003) , 10.1002/PROS.10236
Masashi Nakayama, Mark L. Gonzalgo, Srinivasan Yegnasubramanian, Xiaohui Lin, Angelo M. De Marzo, William G. Nelson, GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. Journal of Cellular Biochemistry. ,vol. 91, pp. 540- 552 ,(2004) , 10.1002/JCB.10740
Mohammad Obaidul Hoque, DNA methylation changes in prostate cancer: current developments and future clinical implementation. Expert Review of Molecular Diagnostics. ,vol. 9, pp. 243- 257 ,(2009) , 10.1586/ERM.09.10
Hideki Enokida, Hiroaki Shiina, Shinji Urakami, Mikio Igawa, Tatsuya Ogishima, Deepa Pookot, Long-Cheng Li, Z. Laura Tabatabai, Motoshi Kawahara, Masayuki Nakagawa, Christopher J. Kane, Peter R. Carroll, Rajvir Dahiya, Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. International Journal of Cancer. ,vol. 116, pp. 174- 181 ,(2005) , 10.1002/IJC.21017
J. G. Herman, J. R. Graff, S. Myohanen, B. D. Nelkin, S. B. Baylin, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 9821- 9826 ,(1996) , 10.1073/PNAS.93.18.9821
Gyeong Hoon Kang, Sun Lee, Hyeon Joo Lee, Kyu Sang Hwang, Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. The Journal of Pathology. ,vol. 202, pp. 233- 240 ,(2004) , 10.1002/PATH.1503
MICHAEL L. BLUTE, ERIK J. BERGSTRALH, ANGELO IOCCA, BETH SCHERER, HORST ZINCKE, Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. The Journal of Urology. ,vol. 165, pp. 119- 125 ,(2001) , 10.1097/00005392-200101000-00030